JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB102420

Goat Anti-Human IgG+IgM+IgA H&L (HRP)

Be the first to review this product! Submit a review

|

(8 Publications)

Suitable for ICC, IHC-P, ELISA, WB. Ideal for western blot. Cited in 8 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2, Immunoglobulin heavy constant alpha 2, Ig alpha-2 chain C region, Ig alpha-2 chain C region BUT, Ig alpha-2 chain C region LAN, IGHA2, Immunoglobulin heavy constant mu, Ig mu chain C region, Ig mu chain C region BOT, Ig mu chain C region GAL, Ig mu chain C region OU, IGHM, Immunoglobulin heavy constant alpha 1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, IGHA1

Key facts

Host species

Goat

Target species

Human

Target isotype

IgA, IgG, IgM

Target specificity

Heavy & Light chains

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

HRP

Excitation/Emission
Applications

IHC-P, ICC, WB, ELISA

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

By immunoelectrophoresis and ELISA this antibody reacts with human IgG, IgA and IgM. No antibody was detected against non-immunoglobulin serum proteins. This antibody may cross react with immunoglobulins from other species.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/5000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>ELISA - Primary</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/5000 - 1/50000", "notes":"<p>WB - Colorimetric: 1/5000 - 1/30000; WB - Chemiluminescent: 1/10000 - 1/50000</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to HRP.
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.05% CMIT/MIT based preservative Constituents: 0.2% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG4,IGHA1,IGHA2,IGHG3,IGHG2,IGHM

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Medical archives (Sarajevo, Bosnia and Herzegovina) 79:287-291 PubMed41064272

2025

Role of Anti-Vinculin Quantitative ELISA Test in Diagnosing Irritable Bowel Syndrome and Inflammatory Bowel Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Tran Khanh Chi,Nguyen Thi Le My,Hoang Hai Yen,Dinh Thi Q Ngoc,Nguyen Thu Huong,Dao Viet Hang,Nguyen Minh Hien

EMBO molecular medicine 16:2638-2651 PubMed39160301

2024

An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Shivneet K Gill,Seiji N Sugiman-Marangos,Greg L Beilhartz,Elizabeth Mei,Mikko Taipale,Roman A Melnyk

Heliyon 10:e29338 PubMed38665565

2024

Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Narjes Saheb Sharif-Askari,Shirin Hafezi,Fatemeh Saheb Sharif-Askari,Hawra Ali Hussain Alsayed,Samrein B M Ahmed,Habiba S Alsafar,Rabih Halwani

Scientific reports 13:17344 PubMed37833265

2023

Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons.

Applications

Unspecified application

Species

Unspecified reactive species

Fatemeh Saheb Sharif-Askari,Narjes Saheb Sharif-Askari,Shirin Hafezi,Hawra Ali Hussain Alsayed,Balachandar Selvakumar,Mariam Wed Abdelaziz Eladham,Bushra Mdkhana,Ola Salam Bayram,Mohamad-Hani Temsah,Rabih Halwani

Immunity 56:1910-1926.e7 PubMed37478854

2023

Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids.

Applications

Unspecified application

Species

Unspecified reactive species

Jenna M Kastenschmidt,Suhas Sureshchandra,Aarti Jain,Jenny E Hernandez-Davies,Rafael de Assis,Zachary W Wagoner,Andrew M Sorn,Mahina Tabassum Mitul,Aviv I Benchorin,Elizabeth Levendosky,Gurpreet Ahuja,Qiu Zhong,Douglas Trask,Jacob Boeckmann,Rie Nakajima,Algimantas Jasinskas,Naresha Saligrama,D Huw Davies,Lisa E Wagar

The oncologist 26:e1619-e1632 PubMed34018280

2021

Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and Mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Miguel Esperança-Martins,Lisa Gonçalves,Inês Soares-Pinho,Andreia Gomes,Marta Serrano,Birte Blankenhaus,Patrícia Figueiredo-Campos,Ana Catarina-Marques,Ana Castro-Barbosa,Ana Cardoso,Pedro Antunes-Meireles,Henrique Atalaia-Barbacena,Pedro Gaspar,Patrícia Howell-Monteiro,António Pais-de-Lacerda,Catarina Mota,Marc Veldhoen

European journal of immunology 50:2025-2040 PubMed33084029

2020

Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.

Applications

Unspecified application

Species

Unspecified reactive species

Patrícia Figueiredo-Campos,Birte Blankenhaus,Catarina Mota,Andreia Gomes,Marta Serrano,Silvia Ariotti,Catarina Costa,Helena Nunes-Cabaço,António M Mendes,Pedro Gaspar,M Conceição Pereira-Santos,Fabiana Rodrigues,Jorge Condeço,M Antonia Escoval,Matilde Santos,Mario Ramirez,José Melo-Cristino,J Pedro Simas,Eugenia Vasconcelos,Ângela Afonso,Marc Veldhoen

Parasites & vectors 11:82 PubMed29409517

2018

Isolation and purification of glycosylphosphatidylinositols (GPIs) in the schizont stage of Theileria annulata and determination of antibody response to GPI anchors in vaccinated and infected animals.

Applications

Unspecified application

Species

Unspecified reactive species

Toktam Abbasnia,Ahmad Asoodeh,Gholamreza Habibi,Alireza Haghparast
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com